Mark Febbraio

Professor

Accepting PhD Students

PhD projects

Our research is focused on identifying genes, proteins and pathways that are important in metabolic disease and certain types of obesity related cancer, and then to develop pharmaceutical therapies that either activate or block the pathway of interest. We currently have several drug candidates that we are exploring and PhD projects that address these areas.

1993 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Mark A Febbraio 

Professor Mark Febbraio is a Senior Principal Research Fellow of the NHMRC, and the Head of the Cellular and Molecular Metabolism Laboratory within the Drug Discovery Program at Monash Institute of Pharmaceutical Sciences, Monash University Australia. He is also the CSO of N-Gene Research Laboratories Inc., a USA based Biotechnology Company and the Founder and CSO of the recently incorporated company Kinomedica. His research is focussed on understanding mechanisms associated with exercise, obesity, type 2 diabetes and cancer and his aim is to develop novel drugs to treat lifestyle related diseases. He has authored over 260 peer reviewed papers in leading journals, has over 35,000 career citations and an H factor of 105. He has won prizes at international, national and institutional levels including the A K McIntyre Prize for significant contributions to Australian Physiological Science (1999), the ESA/ADS Joint Plenary Lecture (2009), the Sandford Skinner Oration from the University of Melbourne (2011), Eureka Scientific Prize Finalist (2013) and the Kellion Award for the Australian Diabetes Society (2017). 

Research area keywords

  • Cell Metabolism
  • Diabetes
  • Cancer Biology
  • Exercise physiology

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.